Literature DB >> 30311777

Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.

Angela R Bazzi1, Dea L Biancarelli2,3, Ellen Childs2, Mari-Lynn Drainoni2,4,3,5, Alberto Edeza6,7, Peter Salhaney6,7, Matthew J Mimiaga6,7,8,9,10, Katie B Biello6,7,8,9.   

Abstract

People who inject drugs (PWID) experience sexual and injection-related HIV risks, but uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among PWID has been low. Improving PrEP uptake in this population will require understanding of PrEP knowledge and interest. In 2017, we conducted in-depth, semistructured interviews with HIV-uninfected PWID and key informants (PrEP and harm reduction providers) in the US Northeast. Thematic analysis of coded data explored PrEP knowledge and the factors that influence PrEP interest. Among PWID (n = 33), median age was 36 years, 55% were male, 67% were white, and 24% identified as Hispanic/Latino. Accurate PrEP knowledge among PWID was low, which key informants (n = 12) attributed to PrEP marketing focused on other risk populations, as well as healthcare providers' lack of time and unwillingness to discuss PrEP with PWID. There was a discrepancy between self-reported HIV risk behaviors, which were common, and HIV risk perceptions, which varied and strongly influenced PrEP interest. Most PWID and key informants thought that PrEP would be most beneficial for those who shared syringes, used discarded syringes, engaged in transactional sex, or were homeless. Improving uptake of PrEP for HIV prevention among high-risk PWID will require education to increase PrEP knowledge and addressing factors that negatively influence PrEP interest such as perceptions regarding low HIV risk and the process for obtaining PrEP. This may require specialized PrEP marketing and outreach efforts and improved capacity of healthcare providers to effectively assess HIV risk (and perceptions) and communicate the benefits of PrEP to at-risk PWID.

Entities:  

Keywords:  HIV infections; harm reduction; needle sharing; pre-exposure prophylaxis; risk taking; sexual behavior

Mesh:

Substances:

Year:  2018        PMID: 30311777      PMCID: PMC6300044          DOI: 10.1089/apc.2018.0126

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  42 in total

1.  HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.

Authors:  Leah M Adams; Benjamin H Balderson
Journal:  AIDS Care       Date:  2016-02-26

Review 2.  An Information-Motivation-Behavioral Skills Model of PrEP Uptake.

Authors:  Alex Dubov; Frederick L Altice; Liana Fraenkel
Journal:  AIDS Behav       Date:  2018-11

3.  Brief motivational intervention to reduce alcohol and HIV/sexual risk behavior in emergency department patients: A randomized controlled trial.

Authors:  Peter M Monti; Nadine R Mastroleo; Nancy P Barnett; Suzanne M Colby; Christopher W Kahler; Don Operario
Journal:  J Consult Clin Psychol       Date:  2016-03-17

4.  Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC).

Authors:  Bisola O Ojikutu; Laura M Bogart; Molly Higgins-Biddle; Sannisha K Dale; Wanda Allen; Tiffany Dominique; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2018-11

5.  HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.

Authors:  Tanya L Kowalczyk Mullins; Gregory Zimet; Michelle Lally; Jiahong Xu; Sarah Thornton; Jessica A Kahn
Journal:  AIDS Patient Care STDS       Date:  2017-12       Impact factor: 5.078

6.  The changing face of heroin use in the United States: a retrospective analysis of the past 50 years.

Authors:  Theodore J Cicero; Matthew S Ellis; Hilary L Surratt; Steven P Kurtz
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

7.  "I felt like a superhero": the experience of responding to drug overdose among individuals trained in overdose prevention.

Authors:  Karla D Wagner; Peter J Davidson; Ellen Iverson; Rachel Washburn; Emily Burke; Alex H Kral; Miles McNeeley; Jennifer Jackson Bloom; Stephen E Lankenau
Journal:  Int J Drug Policy       Date:  2013-08-09

8.  Stigma at every turn: Health services experiences among people who inject drugs.

Authors:  Catherine E Paquette; Jennifer L Syvertsen; Robin A Pollini
Journal:  Int J Drug Policy       Date:  2018-04-30

9.  Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial.

Authors:  Phillip Oliver Coffin; Glenn-Milo Santos; Tim Matheson; Emily Behar; Chris Rowe; Talia Rubin; Janelle Silvis; Eric Vittinghoff
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

10.  Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention.

Authors:  Suzan M Walters; Kathleen H Reilly; Alan Neaigus; Sarah Braunstein
Journal:  Harm Reduct J       Date:  2017-06-29
View more
  44 in total

1.  Advancing the HIV Pre-Exposure Prophylaxis Continuum: A Collaboration Between a Public Health Department and a Federally Qualified Health Center in the Southern United States.

Authors:  Meredith E Clement; Barbara E Johnston; Cedar Eagle; Destry Taylor; Anna Lina Rosengren; Benjamin A Goldstein; Arlene C Seña
Journal:  AIDS Patient Care STDS       Date:  2019-06-24       Impact factor: 5.078

2.  A missing perspective: injectable pre-exposure prophylaxis for people who inject drugs.

Authors:  K B Biello; A Edeza; P Salhaney; D L Biancarelli; M J Mimiaga; M L Drainoni; E S Childs; A R Bazzi
Journal:  AIDS Care       Date:  2019-03-01

3.  Strategies used by people who inject drugs to avoid stigma in healthcare settings.

Authors:  Dea L Biancarelli; Katie B Biello; Ellen Childs; M Drainoni; Peter Salhaney; Alberto Edeza; Matthew J Mimiaga; Richard Saitz; Angela R Bazzi
Journal:  Drug Alcohol Depend       Date:  2019-03-08       Impact factor: 4.492

4.  Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study.

Authors:  Sean T Allen; Allison O'Rourke; Rebecca Hamilton White; Katherine C Smith; Brian Weir; Gregory M Lucas; Susan G Sherman; Suzanne M Grieb
Journal:  AIDS Behav       Date:  2020-06

5.  The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.

Authors:  Suzan M Walters; Bethany Coston; Alan Neaigus; Alexis V Rivera; Lila Starbuck; Valentina Ramirez; Kathleen H Reilly; Sarah L Braunstein
Journal:  Int J Drug Policy       Date:  2020-02-21

6.  Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast.

Authors:  Pablo K Valente; Angela R Bazzi; Ellen Childs; Peter Salhaney; Joel Earlywine; Jennifer Olson; Dea L Biancarelli; Brandon D L Marshall; Katie B Biello
Journal:  Int J Drug Policy       Date:  2020-09-07

7.  Ecological momentary assessment of daily drug use and harm reduction service utilization among people who inject drugs in non-urban areas: A concurrent mixed-method feasibility study.

Authors:  Katie Biello; Peter Salhaney; Pablo K Valente; Ellen Childs; Jennifer Olson; Joel J Earlywine; Brandon Dl Marshall; Angela R Bazzi
Journal:  Drug Alcohol Depend       Date:  2020-07-10       Impact factor: 4.492

8.  HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.

Authors:  Suzan M Walters; Alex H Kral; Kelsey A Simpson; Lynn Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2020-09-23       Impact factor: 2.164

9.  HIV Pre-exposure Prophylaxis for People Who Inject Drugs: The Context of Co-occurring Injection- and Sexual-Related HIV Risk in the U.S. Northeast.

Authors:  Alberto Edeza; Angela Bazzi; Peter Salhaney; Dea Biancarelli; Ellen Childs; Matthew J Mimiaga; Mari-Lynn Drainoni; Katie Biello
Journal:  Subst Use Misuse       Date:  2019-10-09       Impact factor: 2.164

10.  High Prevalence of Indications for Pre-exposure Prophylaxis Among People Who Inject Drugs in Boston, Massachusetts.

Authors:  Joel J Earlywine; Angela R Bazzi; Katie B Biello; R Monina Klevens
Journal:  Am J Prev Med       Date:  2020-11-21       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.